News & Updates

Patients with symptomatic peripheral artery disease and type 2 diabetes see notable improvements in their walking capacity and quality of life with once-weekly semaglutide injections in the phase 3b STRIDE study.

Children who survived central nervous system (CNS) infections experience many endocrinologic imbalances, according to a study. Of these infections, meningitis poses the highest risk of subsequent endocrinopathies, particularly short stature.

Treatment with tirzepatide once weekly results in significant decreases in glycated haemoglobin A1c (HbA1c) and body weight (BW), regardless of antiglutamic acid decarboxylase autoantibodies (GADA) status in adults with type 2 diabetes (T2D), according to a post hoc analysis of SURPASS.

Poor glycaemic status may predispose individuals with type 2 diabetes (T2D) to dementia, with the risk especially high in those experiencing significant fluctuations in glycaemic levels, as reported in a retrospective cohort study.